Stem Cell Mobilization, Collection, and Processing.
作者信息
Kriegsmann Katharina, Wuchter Patrick
机构信息
Laborarztpraxis Rhein-Main MVZ GbR, Frankfurt am Main, Germany.
Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University; German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany.
出版信息
Transfus Med Hemother. 2023 Sep 5;50(5):369-370. doi: 10.1159/000533649. eCollection 2023 Oct.
Abstract
摘要
相似文献
1
Stem Cell Mobilization, Collection, and Processing.干细胞动员、采集与处理。
Transfus Med Hemother. 2023 Sep 5;50(5):369-370. doi: 10.1159/000533649. eCollection 2023 Oct.
2
Scoping Review of Factors Associated with Stem Cell Mobilization and Collection in Allogeneic Stem Cell Donors.异体造血干细胞捐献者中与干细胞动员和采集相关因素的范围性综述
Transplant Cell Ther. 2024 Sep;30(9):844-863. doi: 10.1016/j.jtct.2024.06.002. Epub 2024 Jun 6.
3
[Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].[亲缘与非亲缘供者造血干细胞动员采集的安全性比较]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1017-22.
4
[A retrospective analysis of autologous peripheral blood hematopoietic stem cell mobilizations and collections in 149 multiple myeloma patients].[149例多发性骨髓瘤患者自体外周血造血干细胞动员及采集的回顾性分析]
Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):367-71. doi: 10.3760/cma.j.issn.0253-2727.2015.05.003.
5
[Efficacy and Safety of Plerixafor Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Lymphoma Patients].普乐沙福联合粒细胞集落刺激因子用于淋巴瘤患者自体外周血造血干细胞动员的疗效与安全性
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1056-1060. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.020.
6
Autologous Stem Cell Mobilization and Collection.自体干细胞动员与采集
Hematol Oncol Clin North Am. 2016 Jun;30(3):573-89. doi: 10.1016/j.hoc.2016.01.004.
7
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.外周血造血干细胞动员及采集效果并非自体干细胞移植的独立预后因素。
Transfusion. 2007 Dec;47(12):2207-16. doi: 10.1111/j.1537-2995.2007.01448.x. Epub 2007 Aug 21.
8
[Application of Mecapegfilgrastim for Peripheral Blood Hematopoietic Stem Cell Mobilization in Patients With Hematologic Neoplasms and Analysis of Predictors for Poor Mobilization].[美卡培格司亭在血液系统肿瘤患者外周血造血干细胞动员中的应用及动员不佳的预测因素分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):625-630. doi: 10.12182/20230560103.
9
Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma Patients.局部放疗在诱导期前后会延迟多发性骨髓瘤患者的干细胞动员和采集。
Transplant Cell Ther. 2021 Oct;27(10):876.e1-876.e11. doi: 10.1016/j.jtct.2021.06.025. Epub 2021 Jun 30.
10
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.预先给予普乐沙福治疗对多发性骨髓瘤患者干细胞动员的临床和成本结果。
Leuk Res. 2019 Oct;85:106215. doi: 10.1016/j.leukres.2019.106215. Epub 2019 Aug 9.
引用本文的文献
1
Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?确定在多发性骨髓瘤挽救性移植中有效利用储存自体外周血干细胞的候选者：谁获益最大？
Hematol Rep. 2024 Jul 12;16(3):479-486. doi: 10.3390/hematolrep16030046.
本文引用的文献
1
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.一项关于德国范围内多发性骨髓瘤动员不佳患者在自体干细胞移植前造血干细胞动员与采集的系统性研究。
Transfus Med Hemother. 2023 Oct 16;50(6):475-490. doi: 10.1159/000531935. eCollection 2023 Dec.
2
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.达雷妥尤单抗、硼替佐米、沙利度胺和地塞米松方案与硼替佐米、环磷酰胺和地塞米松方案用于新诊断多发性骨髓瘤患者自体干细胞采集的比较
Transfus Med Hemother. 2023 Mar 24;50(5):371-381. doi: 10.1159/000529691. eCollection 2023 Oct.
3
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.临床参数和诱导方案对多发性骨髓瘤患者外周血干细胞动员及采集的影响
Transfus Med Hemother. 2023 Jun 5;50(5):382-395. doi: 10.1159/000530056. eCollection 2023 Oct.
4
Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors.预测健康异基因供者造血干细胞采集的成功率
Transfus Med Hemother. 2023 Jun 30;50(5):396-402. doi: 10.1159/000531236. eCollection 2023 Oct.
5
Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation.适用于自体造血细胞移植的骨髓瘤患者的动员策略
Transfus Med Hemother. 2023 Aug 24;50(5):438-447. doi: 10.1159/000531940. eCollection 2023 Oct.
6
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.淋巴瘤动员不佳患者的动员及造血干细胞采集：德国OPTIMOB研究的最终结果
Transfus Med Hemother. 2023 Sep 21;50(5):403-416. doi: 10.1159/000531936. eCollection 2023 Oct.
7
Flow Cytometric Characterization of Hematopoietic Stem and Progenitor Cell Subpopulations in Autologous Peripheral Blood Stem Cell Preparations after Cryopreservation.冷冻保存后自体外周血干细胞制品中造血干细胞和祖细胞亚群的流式细胞术特征分析
Transfus Med Hemother. 2023 Sep 15;50(5):417-427. doi: 10.1159/000533624. eCollection 2023 Oct.
8
CD34 Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients.套细胞淋巴瘤患者的CD34细胞动员、自体移植细胞组成及预后
Transfus Med Hemother. 2023 Aug 23;50(5):428-437. doi: 10.1159/000531799. eCollection 2023 Oct.
9
Comparison between intermittent and continuous spectra optia leukapheresis systems for autologous peripheral blood stem cell collection.用于自体外周血干细胞采集的间歇性和连续性光谱Optia白细胞去除术系统之间的比较。
J Clin Apher. 2017 Feb;32(1):27-34. doi: 10.1002/jca.21463. Epub 2016 Apr 20.
10
HPC-A dose prediction on the optia® cell separator based on a benchmark CE2 collection efficiency: Promoting clinical efficiency, minimizing toxicity, and allowing quality control.基于基准CE2采集效率的Optia®细胞分离器上的HPC-A剂量预测：提高临床效率、将毒性降至最低并实现质量控制。
J Clin Apher. 2015 Dec;30(6):321-8. doi: 10.1002/jca.21380. Epub 2015 Jan 24.
Zotero 插件